Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Multiple Cancer Types
This is a Phase 1, open label, multi center, dose escalation and expansion, safety, tolerability, PK, and pharmacodynamics study of PF 06939999 in previously treated patients with advanced or metastatic cancer.
Bladder,
Cervical,
Esophageal,
Head/Neck,
Lung,
Non Small Cell,
Phase I,
Uterine
I
Berlin, Jordan
NCT03854227
VICCPHI1909
